Equity Overview
Price & Market Data
Price: $0.0142
Daily Change: -$0.0₃2 / 1.41%
Daily Range: $0 - $0
Market Cap: $1,726,187
Daily Volume: 0
Performance Metrics
1 Week: -2.07%
1 Month: -16.96%
3 Months: -19.32%
6 Months: 35.24%
1 Year: -27.55%
YTD: -16.96%
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine for the treatment of francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.